Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

Chemoprevention of prostate cancer by second-generation selenium compounds in reference to selenomethionine holds strong promise to deal with the disease at the root. Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Wang, Lei, Bonorden, Melissa J. L., Li, Guang-xun, Lee, Hyo-Jeong, Hu, Hongbo, Zhang, Yong, Liao, Joshua D., Cleary, Margot P., Lü, Junxuan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822708/
https://ncbi.nlm.nih.gov/pubmed/19401524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0173
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items